Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The MUSTT study: evaluating testing and treatment.

H U Klein1, S Reek

  • 1Division of Cardiology, University Hospital Magdeburg, Germany. Helmut.Klein@medizin.uni-magdeburg.de.

Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|December 11, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Patients with a wearable cardioverter-defibrillator (WCD) : Prescription, function and rehabilitation support].

Herz·2017
Same author

[Not Available].

Herzschrittmachertherapie & Elektrophysiologie·2014
Same author

[Pathophysiology of pacing in patients with atrial fibrillation].

Herzschrittmachertherapie & Elektrophysiologie·2014
Same author

WCD LifeVest: risk stratification in a case of Tako-Tsubo cardiomyopathy with QT interval prolongation.

Herz·2011
Same author

[Chance for young electrophysiologists: the continuing education program "Fellowship heart rhythm"].

Herzschrittmachertherapie & Elektrophysiologie·2010
Same author

[Not Available].

Herzschrittmachertherapie & Elektrophysiologie·2009
Same journal

Sex differences in escalation to atrioventricular node ablation following catheter ablation for atrial fibrillation.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same journal

Focal pulsed field ablation for complex ventricular arrhythmias after prior failed or intraprocedurally ineffective radiofrequency ablation.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same journal

Machine learning prediction of mechanical dilatation in transvenous lead extraction for cardiac device-related infections: insights from a high-volume centre.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same journal

Heterogeneity in endpoints, monitoring methods and blanking periods in clinical trials of atrial fibrillation ablation: a systematic review and meta-analysis.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same journal

Procedural characteristics and acute outcomes with different pulsed field ablation systems for atrial fibrillation.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same journal

Clinical outcomes after catheter ablation for atrial fibrillation in elderly patients: a meta-analysis with time-to-event data reconstruction.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
See all related articles

The MUSTT trial found electrophysiologically guided antiarrhythmic drugs offer limited benefit for high-risk patients. Implantable cardioverter-defibrillators (ICDs) significantly reduce sudden cardiac death risk in these patients.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Clinical Trials

Background:

  • Nonsustained ventricular tachycardia (NSVT) and poor left ventricular function (LV-EF ≤ 40%) in coronary artery disease (CAD) patients identify high risk for sudden cardiac death (SCD).
  • Electrophysiologically guided therapy aims to prevent adverse outcomes in these patients.

Purpose of the Study:

  • To evaluate the efficacy of electrophysiologically guided antiarrhythmic drug (AAD) therapy versus no therapy in high-risk CAD patients with NSVT.
  • To assess the role of inducibility testing in risk stratification for sudden arrhythmic death or cardiac arrest (SCD/CA).

Main Methods:

  • The Multicenter Unsustained Tachycardia Trial (MUSTT) enrolled high-risk CAD patients with LV-EF ≤ 40% and NSVT.
  • Patients underwent electrophysiological (EP) testing to assess inducibility of sustained ventricular tachycardia.

Related Experiment Videos

  • Participants were randomized to EP-guided AAD therapy or no therapy, with a primary endpoint of SCD/CA.

    • Main Results:

    • EP-guided AAD therapy showed a trend towards reduced SCD/CA compared to no treatment (18% vs. 32% at 60 months).
    • Subgroup analysis revealed that the benefit of AADs was primarily associated with concurrent implantable cardioverter-defibrillator (ICD) implantation.
    • Patients who were not inducible for sustained ventricular tachycardia had significantly better outcomes regardless of treatment, highlighting inducibility as a key risk stratifier.

    Conclusions:

    • Electrophysiological testing is a crucial tool for risk stratification in high-risk CAD patients.
    • Stand-alone antiarrhythmic drug therapy guided by EP testing has limited value in preventing SCD/CA.
    • Implantable cardioverter-defibrillators (ICDs) are essential for significantly reducing SCD/CA in this patient population, as demonstrated by MUSTT findings supporting MADIT study data.